Bellevue Life Sciences Acquisition Corp. (BLAC)

USD 11.32

(0.0%)

Market Cap (In USD)

45.74 Million

Revenue (In USD)

-

Net Income (In USD)

403.78 Thousand

Avg. Volume

6112.00

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
10.46-13.4
PE
-
EPS
-
Beta Value
-0.008123183
ISIN
US0791741087
CUSIP
079174108
CIK
1840425
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Shell Companies
CEO
Mr. Kuk Hyoun Hwang
Employee Count
-
Website
-
Ipo Date
2023-03-21
Details
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.